![Robert Brodell MD, FAAD](https://res.cloudinary.com/els-assets/image/upload/f_auto,w_120,c_thumb,ar_1:1,g_face/r_max,bo_2px_solid_rgb:d3d3d37F/practice-update/remote-media/contentimage/14802.jpg)
Robert T. Brodell MD, FAAD
Professor and Chair, Department of Pathology; Past Founding Chair, Department of Dermatology; Billy S. Guyton Distinguished Professor, University of Mississippi Medical Center, Jackson, MississippiAfter founding the Department of Dermatology at the University of Mississippi Medical Center in 2013, Dr. Robert T. Brodell is now tenured Professor and Chair of the Department of Pathology. His research focuses on human papillomavirus and translational research — moving science to the treatment room. His clinical interests include general dermatology, procedural dermatology, dermatopathology, and warts. In addition to his involvement in teaching, he has a strong interest in the ethics of dermatology, in tips and tricks for procedural dermatology, and in access to care in rural America. He also serves as a part-time staff physician at the Sonny Montgomery Veterans Administration Hospital in Jackson, Mississippi.
A dedicated teacher, he has performed almost 2000 lectures in his career and is the recipient of the Thomas G. Pearson, EdD, Memorial Education Award of the American Academy of Dermatology in 2018. He is also a dedicated volunteer for the American Cancer Society and a member of the Relay For Life Hall of Fame.
Dr. Brodell is an associate editor of the Journal of the American Academy of Dermatology, and he serves on the editorial boards of the American Medical Student Research Journal, where he is faculty advisor to the editorial board, Practical Dermatology, Journal of the Mississippi State Medical Society, and SKIN: The Journal of Cutaneous Medicine.
Disclosures
- Multicenter clinical trials: Novartis (principal investigator); CorEvitas (psoriasis biologic registry)
- Educational grant: Pfizer
Recent Contributions to PracticeUpdate:
- Crisaborole 2% Ointment for the Treatment of Intertriginous, Anogenital, and Facial Psoriasis
- Variability in Wound Care Recommendations Following Dermatologic Procedures
- High-Resolution HLA Typing Identifies a New "Super Responder" Subgroup of HLA-C*06:02–Positive Psoriatic Patients
- Online Sunscreen Purchases: Impact of Product Characteristics and Marketing Claims
- Highlights and Implications of the 2019 Proposed Rule on Sunscreens by the FDA
- Should the Target of Psoriasis Therapy Be 100% Clearance? Update From the Noah Worcester Dermatological Society 2019 Annual Meeting
- Establishing a Young Adult Dermatology Clinic With Specialist Psychological Support
- Herpes Zoster Incidence and Consensus Recommendations on Vaccination in Adults on Systemic Therapy for Psoriasis or Psoriatic Arthritis
- Are There Distinct Clinical and Pathological Features Distinguishing Idiopathic From Drug-Induced Subacute Cutaneous Lupus Erythematosus?
- Improving Non-Attendance Rates Among Pediatric Patients With Medicaid or Private Insurance